Etiracetam
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Etiracetam
|
|
| Systematic (IUPAC) name | |
| 2-(2-oxopyrrolidin-1-yl)butanamide | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C8H14N2O2 |
| Mol. mass | 170.209 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled (US) |
| Routes | Oral |
Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active optical form is levetiracetam.
[edit] See also
|
|||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
